Joseph Frjelich, in Apo, AE - Physician Assistant

Joseph Frjelich, is a Physician Assistant based in Apo, Armed Forces Europe. Joseph Frjelich is licensed to practice in * (Not Available) (license number ) and his current practice location is Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, Armed Forces Europe. He can be reached at his office (for appointments etc.) via phone at (314) 590-2368.

NPI number for Joseph Frjelich is 1013373323 and his current mailing address is Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, Armed Forces Europe. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013373323.

Contact Information

	Joseph Frjelich,
	Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112
	(314) 590-2368
	Not Available

Healthcare Provider's Profile

Full Name	Joseph Frjelich
Gender	Male
Speciality	Physician Assistant
Location	Hq Meddac Bavaria, Apo, Armed Forces Europe
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013373323
Provider Enumeration Date: 01/04/2016
Last Update Date: 04/06/2022

Medical Identifiers

Medical identifiers for Joseph Frjelich such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013373323	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	070.021481 (Illinois)	Secondary
363A00000X	Physician Assistant	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Joseph Frjelich is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Joseph Frjelich, Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Ph: () -	Joseph Frjelich, Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Ph: (314) 590-2368

News Archive

STEM workshop highlights the need to impart advanced training and education on clean, sustainable pharmaceutical manufacturing

DSM Sinochem Pharmaceuticals, global leader in sustainable antibiotics, in collaboration with the Indian Institute of Technology, New Delhi organized a workshop today on 'Sustainability through Excellence in Manufacturing (STEM)' to impart advanced training and education to industry stakeholders on high quality, clean and sustainable pharmaceutical manufacturing.

U.S. officials step up enforcement of 'responsible corporate officer doctrine' to pursue violations of federal food and drug laws

Use of this doctrine allows federal officials to hold health care executives personally and criminally responsible for corporate violations. Meanwhile, in other news related to health care fraud and abuse, a number of states have reached settlements with firms accused of defrauding the Medicaid program.

Pneumococcal vaccine pre-clinical development supported by £0.2 million award from Biomedical Catalyst

ImmBio (Immunobiology Ltd), a biopharmaceutical company developing innovative vaccines against serious infectious diseases, today announced that the UK government-backed Biomedical Catalyst has awarded the company approximately £0.2 million ($0.3 million) to support pre-clinical development of its pneumococcal vaccine, PnuBioVax™, which targets a wide range of strains of the bacteria.

Study: BMP can improve dental implant success

Using a bone-creating protein to augment the maxillary sinus could improve dental implant success, according to Georgia Health Sciences University researchers.

New trial data shows that BIOTRONIK monitoring system is safe and effective for detecting patients' clinical events

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, today announced that new data from the TRUST (Lumos-T Safely Reduces Routine Office Device Follow Up) trial presented at the European Society of Cardiology Congress 2009 demonstrate the benefits of BIOTRONIK Home Monitoring in the early detection of patient clinical events as well as the safe reduction of in-office follow-up visits.

Joseph Frjelich, - in Apo, AE